Management of Hypertryptasemia

Diagnostic Workup Priority

The National Comprehensive Cancer Network recommends bone marrow assessment as mandatory given the tryptase level exceeding 20 μg/L, which is a diagnostic criterion for systemic mastocytosis 2
The National Comprehensive Cancer Network suggests obtaining bone marrow biopsy to assess for dense mast cell infiltrates and perform KIT D816V mutation testing, as these are major and minor criteria for systemic mastocytosis diagnosis respectively 2
Measuring 24-hour urine mast cell mediators, including N-methylhistamine, leukotriene E4, and 2,3-dinor-11β-prostaglandin F2α, during symptomatic episodes can characterize the mediator profile 3
Documenting baseline tryptase after acute symptoms resolve can establish a personal baseline for future comparison 1, 4

The American College of Allergy, Asthma, and Immunology recommends initiating dual antihistamine blockade immediately as first-line prophylaxis, regardless of symptom presence, given the markedly elevated tryptase indicating significant mast cell burden 1, 3
Starting an H1 antihistamine, such as cetirizine 20-40 mg daily or fexofenadine 360-720 mg daily, is recommended 3
Adding an H2 antihistamine, such as famotidine 40 mg twice daily, is also recommended 1, 3
Considering adding oral cromolyn sodium 200 mg four times daily after gradual dose escalation, as it is FDA-approved specifically for mastocytosis 3

The American Heart Association notes that the combination of aspirin and elevated tryptase creates heightened anaphylaxis risk, requiring specific precautions 1
Continuing aspirin for cardiovascular protection is recommended, but it increases both anaphylaxis risk and can paradoxically trigger mast cell activation in some patients 1, 3
Maintaining statin therapy, such as simvastatin, is recommended, as the cardiovascular benefit outweighs risks, but be aware that statins do not directly interact with mast cell disorders 5, 6
Continuing amlodipine, a calcium channel blocker, is safe in this context and does not trigger mast cell activation 7, 8

The National Comprehensive Cancer Network recommends avoiding temperature extremes, alcohol, physical trauma or friction to skin, psychological stress, and vigorous exercise to prevent mast cell activation episodes 1, 3
Avoiding high-risk medications, such as opiates, muscle relaxants, and NSAIDs beyond aspirin, is recommended 2
Using safe alternatives, such as fentanyl or remifentanil for analgesia, and rocuronium or vecuronium for muscle relaxation, is recommended 2

The National Comprehensive Cancer Network suggests that any future surgical or invasive procedures require specialized premedication protocols given the elevated tryptase 2, 4
Premedicating with benzodiazepines, H1 and H2 antihistamines, and corticosteroids, such as hydrocortisone 200 mg IV, is recommended 2, 4
Coordinating with the anesthesia team to review safe anesthetic agents, such as propofol, sevoflurane, or isoflurane, is recommended 2

The American College of Allergy, Asthma, and Immunology recommends establishing clear protocols for acute mast cell activation episodes, which may present as cardiovascular collapse 1
First-line treatment with intramuscular epinephrine 0.01 mg/kg, with no absolute contraindications, is recommended 1, 4
Positioning, such as Trendelenburg for hypotension or sitting up for respiratory distress, and fluid resuscitation with rapid IV boluses of normal saline, are recommended 1
An observation period of at least 4 hours after symptom resolution, extending to 24 hours if severe reaction or multiple epinephrine doses are required, is recommended 1

The National Comprehensive Cancer Network recommends serial tryptase measurements during acute episodes to confirm mast cell activation syndrome if systemic mastocytosis is ruled out 1
Measuring tryptase levels within 30-120 minutes of symptom onset, at 1-2 hours, and after 24+ hours of complete symptom resolution, is recommended 1
A mast cell activation syndrome diagnostic threshold of an acute tryptase increase of ≥20% + 2 μg/L above personal baseline, documented on at least 2 separate occasions with concurrent involvement of ≥2 organ systems, is recommended 1